Calamos Advisors LLC Organon & Co. Transaction History

Calamos Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	SELL	$21.42 - $32.08 $138,673 - $207,685	-6,474 Reduced 11.11%	51,781 $1.22 Million
Q4 2022 Jan 25, 2023	SELL	$23.31 - $28.61 $240,069 - $294,654	-10,299 Reduced 15.02%	58,255 $0
Q3 2022 Oct 24, 2022	SELL	$23.4 - $34.25 $93 - $137	-4 Reduced 0.01%	68,554 $1.6 Million
Q2 2022 Aug 01, 2022	BUY	$31.66 - $38.9 $58,444 - $71,809	1,846 Added 2.77%	68,558 $2.31 Million
Q1 2022 May 03, 2022	BUY	$30.45 - $39.36 $270,761 - $349,989	8,892 Added 15.38%	66,712 $2.33 Million
Q4 2021 Feb 01, 2022	BUY	$28.67 - $37.13 $64,163 - $83,096	2,238 Added 4.03%	57,820 $1.76 Million
Q3 2021 Oct 26, 2021	BUY	$28.63 - $35.64 $140,401 - $174,778	4,904 Added 9.68%	55,582 $1.82 Million
Q2 2021 Jul 22, 2021	BUY	$28.45 - $38.0 $1.44 Million - $1.93 Million	50,678 New	50,678 $1.53 Million

790

201M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.17B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Calamos Advisors LLC with notifications on news.